Associate Professor, Epidemiology
Boston University School of Public Health, MPH, DSc
- Office: Crosstown Center, CT372
- Phone: 617-414-1270
- Email: firstname.lastname@example.org
Matthew Fox, DSc, MPH, is Associate Professor in the Center for Global Health & Development and in the Department of Epidemiology at Boston University. Dr. Fox joined the center in 2001. Before joining Boston University, he was a Peace Corps volunteer in the former Soviet Republic of Turkmenistan. His research interests include treatment outcomes in HIV-treatment programs, infectious disease epidemiology (with specific interests in HIV and pneumonia), and epidemiologic methods. Dr. Fox is currently funded through a K award from the National Institutes of Allergy and Infectious Diseases, to work on ways to improve retention in HIV-care programs in South Africa from the time of testing HIV-positive through long-term treatment. As part of this work, he is involved in analyses of whether treating patients at higher CD4 counts leads to improved long-term retention and treatment outcomes. Dr. Fox also does research on quantitative sensitivity analysis and recently co-authored a book on these methods, Applying Quantitative Bias Analysis to Epidemiologic Data. He currently teaches a third-level epidemiologic methods class, Advanced Epidemiology. Dr. Fox is a graduate of the Boston University School of Public Health with a master’s degree in epidemiology and biostatistics and a doctorate in epidemiology.
- AIDS and the Private Sector in Africa
- Economic and Quality of Life Outcomes for Patients on ART in Kenya
- Economics and Epidemiology of HIV/AIDS Care and Treatment (South Africa Associate Award)
- Epidemiologic Analyses and HIV Treatment Outcomes in South Africa
- Factors Influencing Enrollment in Treatment for HIV/AIDS in Zambia
- Hala Community Management of Pneumonia Study (HACOMP)
- ISHED: International Studies in Health and Economic Development
- Labor Productivity and Antiretroviral Therapy in Kenya
- Loss to Follow-up for HIV Treatment in South Africa
- Loss to Initiation of HIV Care and Treatment in South Africa
- Protocol for Program Evaluation of the Antiretroviral – Antenatal Care Integration Project in Southern Zambia
- RapIT: Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa
- The Role of Immunosuppression in Treatment Outcomes
- Use and Outcomes of Second-Line HIV Treatment in South Africa
Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa
Tropical Medicine and International Health. 2013 Apr; 18(4):451-460.
Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa
Tropical Medicine and International Health. 2013 Feb; 18(2):194-198.
Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting
AIDS 2013. 2013 Feb; 27(4):645-650.
Antiretroviral Therapy, Labor Productivity, and Gender: A Longitudinal Cohort Study of Tea Pluckers in Kenya
AIDS 2012. 2013 Jan;.
Patient Retention From HIV Diagnosis Through One Year on Antiretroviral Therapy at a Primary Health Care Clinic in Johannesburg, South Africa
JAIDS. 2013 Jan; 62(2):39-46.
Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa
JAIDS. 2013 Jan; 62(3):322-328.
Low Rates of Treatment Failure in Children 2-59 Months Treated for Severe Pneumonia: A Multi-site Pooled Analysis
Clinical Infectious Diseases. 2013 Jan; 56(7):978-987.
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
Journal of Acquired Immune Deficiency Syndromes. 2012 Aug; 60(4):428-437.
Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa
Tropical Medicine and International Health. 2012 Aug; 00(00):1-10.
Frequency and Trajectory of Abnormalities in Respiratory Rate, Temperature and Oxygen Saturation in Severe Pneumonia In Children
Pediatric Infectious Disease Journal. 2012 Aug; 31(8):863-865.
AIDS 2012. 2012 Jul; 26(6):770-773.
AIDS 2012. 2012 Jun; 26:1823-1828.
How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa
PLoS ONE. 2012 Apr; 7(4):1-8.
International Journal of Epidemiology. 2012 Mar; 10(1093):1-10.
Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV- infected adults initiating HAART in South Africa
Journal of the International AIDS Society. 2012 Mar; 15(1).
Poorer ART Outcomes with Increasing Age at a Large Public Sector HIV Clinic in Johannesburg, South Africa
Journal of the International Association of Physicians in AIDS Care. 2012 Feb; 11(57):57-65.
South Africa: HE2RO Policy Brief Number 4, Health Economics and Epidemiology Research Office; 2012 Jan.
Rapid, Point-of-Care CD4 Testing At Mobile and Fixed HIV Testing Sites: Does It Increase Linkage to HIV Care?
Health Economics and Epidemiology Research Office (HERO). 2011 Nov; 3:1-2.
Community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Haripur district, Pakistan: a cluster randomised tria. 2011 Nov;.
The Lancet. 2011 Nov;.
Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
Infectious Agents and Cancer. 2011 Nov; 6(22):8.
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy
Antiviral Therapy. 2011 Nov; 17:313-320.
Southern Africa Collaboration Long-term Outcomes of Antiretroviral Treatment in Programmes With and Without Routine Viral Load Monitoring in Southern Africa
AIDS. 2011 Sep; 25(14):1761-1769.
JIAPAC. 2011 Sep; 11(1):57-65.
AIDS: Official Journal of the International AIDS Society. 2011 Aug; 24(13):1603-1609.
The Net Cost of Incorporating Resistance Testing into HIV/AIDS Treatment in South Africa: A Markov Model with Primary Data
Journal of International AIDS Society. 2011 Jul; 14(24):1-6.
PLOS Medicine.. 2011 Jul; 8(7):1-16.
Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
PLOS Medicine. 2011 Jul; 8(7):1-10.
PLoS Medicine. 2011 Jul; 8(7):1-16.
Effect of Training Traditional Birth Attendants on Neonatal Mortality (Lufwanyama Neonatal Survival Project): Randomised Controlled Study
British Medical Journal. 2011 Jun;.
Outpatient Treatment of Children With Severe Pneumonia with Oral Amoxicillin in Four Countries: The MASS Study
Tropical Med Int Health. 2011 May;.
Int J Tuberc Lunc Dis. 2011 Jan; 15:1-8.
Correcting mortality for loss to follow up: A nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa
PLoS ONE Medicine. 2011 Jan; 8(1):1-11.
The Importance of Clinic Attendance in the First Six Months on Antiretroviral Treatment (ART): Missing Medical Visits Results in Poorer ART Outcomes
Journal of International AIDS Society. 2010 Dec; 13(49).
Lost Opportunities to Complete CD4+ Lymphocyte Testing Among Patients Who Tested Positive for HIV in South Africa
Bull World Health Organ. 2010 Sep; 88(9):675-80.
Temporal Changes in Programme Outcomes among Adult Patients Initiating Antiretroviral Therapy across South Africa, 2002-2007
AIDS. 2010 Aug; 24(14):2263-70.
Total Cost and Potential Cost Savings of the National Antiretroviral Treatment (ART) Programme in South Africa 2010 to 2017. Abstract 16112
18th International AIDS Conference; 2010 Jul 18; Vienna.
Patient Retention in Antiretroviral Therapy Programs Up to Three Years on Treatment in Sub-Saharan Africa, 2007-2009: Systematic Review
Trop Med Int Health. 2010 Jul; 15 Suppl 1:1-15.
Initiating Patients on Antiretroviral Therapy at CD4 Cell Counts Above 200 Cells/Microl is Associated with Improved Treatment Outcomes in South Africa
AIDS. 2010 Jul; 24(13):2041-50.
Early Loss to Follow Up After Enrolment in Pre-ART Care at a Large Public Clinic in Johannesburg, South Africa
Trop Med Int Health. 2010 Jul; 15 Suppl 1:43-7.
Nurse Versus Doctor Management of HIV-Infected Patients Receiving Antiretroviral Therapy (CIPRA-SA): A Randomised Non-Inferiority Trial
Lancet. 2010 Jun; 376(9734):33-40.
Improvements in Physical Wellbeing over the First Two Years on Antiretroviral Therapy in Western Kenya
AIDS Care. 2010 Apr; 22(2):137-45.
J Natl Cancer Inst. 2010 Apr; 102(11):829-30; author reply 830.
Temporal Trends in Generic and Brand Prices of Antiretroviral Medicines Procured with Donor Funds in Developing Countries
Journal of Generic Medicines. 2010 Apr; 7(2):159-175.
Barriers to Initiation of Antiretroviral Treatment in Rural and Urban Areas of Zambia: A Cross-sectional Study of Cost, Stigma, and Perceptions about ART
J Int AIDS Soc. 2010 Mar; 13:8.
Using Vital Registration Data to Update Mortality among Patients Lost to Follow-up from ART Programmes: Evidence from the Themba Lethu Clinic, South Africa
Trop Med Int Health. 2010 Feb; 15(4):405-13.
Survival in Care and CD4 Cell Count Gain on First-line ART Depend on Prior CD4 Cell Count and Time on Treatment: Evidence From a Large South African Cohort. Abstract Z-184
17th Conference on Retroviruses and Opportunistic Infections (CROI); 2010 Feb 1; San Francisco.
AIDS. 2010 Jan; 24(6):915-9.
Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
PLoS ONE. 2010 Jan; 5(9):e12731.
High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-line Antiretroviral Therapy in South Africa
J Acquir Immune Defic Syndr. 2009 Oct; 53(4):500-6.
Global Strategies to Reduce the Price of Antiretroviral Medicines: Evidence from Transactional Databases
Bull World Health Organ. 2009 Aug; 87(7):520-8.
Do the Socioeconomic Impacts of Antiretroviral Therapy Vary by Gender? A Longitudinal Study of Kenyan Agricultural Worker Employment Outcomes
BMC Public Health. 2009 Jul; 9:240.
High Frequency of Multidrug-Resistant Gram-Negative Rods in 2 Neonatal Intensive Care Units in the Philippines
Infect Control Hosp Epidemiol. 2009 May; 30(6):543-9.
J Epidemiol Community Health. 2009 Jan; 63(2):91.
Effect of Presumptive Co-Trimoxazole Prophylaxis on Pneumococcal Colonization Rates, Seroepidemiology and Antibiotic Resistance in Zambian Infants: A Longitudinal Cohort Study
Bull World Health Organ. 2009 Jan; 86(12):929-38.
Dordrecht ; New York: Springer; 2009.
Role of Breastfeeding Cessation in Mediating the Relationship between Maternal HIV Disease Stage and Increased Child Mortality among HIV-exposed Uninfected Children
Int J Epidemiol. 2008 Dec; 38(2):569-76.
Cost and Cost-Effectiveness of Switching from Stavudine to Tenofovir in First-Line Antiretroviral Regimens in South Africa
J Acquir Immune Defic Syndr. 2008 Jun; 48(3):334-44.
Impact of Human Immunodeficiency Virus Infection on Streptococcus Pneumoniae Colonization and Seroepidemiology among Zambian Women
J Infect Dis. 2008 Apr; 197(7):1000-5.
Reduced Mortality Associated with Breast-feeding-acquired HIV Infection and Breast-feeding among HIV-infected Children in Zambia
J Acquir Immune Defic Syndr. 2008 Mar; 48(1):90-6.
Ambulatory Short-Course High-Dose Oral Amoxicillin for Treatment of Severe Pneumonia in Children: A Randomised Equivalency Trial
Lancet. 2008 Jan; 371(9606):49-56.
Early Effects of Antiretroviral Therapy on Work Performance: Preliminary Results from a Cohort Study of Kenyan Agricultural Workers
AIDS. 2008 Jan; 22(3):421-5.
J Gen Intern Med. 2007 Dec; 23(2):158-63.
PLoS Med. 2007 Oct; 4(10):e298.
AIDS. 2007 Aug; 21 Suppl 3:S53-9.
Impact of HIV-1 Status on the Radiological Presentation and Clinical Outcome of Children with WHO Defined Community-acquired Severe Pneumonia
Arch Dis Child. 2007 Jun; 92(11):976-9.
J Clin Oncol. 2007 Jun; 25(21):3001-6.
JAMA. 2007 May; 297(20):2227-31.
Am J Epidemiol. 2007 Apr; 165(12):1454-61.
Health, Economic Development and Household Poverty: From Understanding to Action. Bennet S., Gilson L., Mills A.. London, England: Taylor and Francis, Routledge; 2007.
International Journal of Epidemiology. 2006 Dec; 35(6):1592-1593.
Brief Hospitalization and Pulse Oximetry for Predicting Amoxicillin Treatment Failure in Children with Severe Pneumonia
Pediatrics. 2006 Dec; 118(6):e1822-30.
International Journal of Epidemiology. 2006 Dec; 35(6):1589-1590.
J Pediatr. 2006 Jul; 149(1):12-6.
Failure of Standard Antimicrobial Therapy in Children Aged 3-59 Months with Mild or Asymptomatic HIV Infection and Severe Pneumonia
Bull World Health Organ. 2006 Apr; 84(4):269-75.
Breast Cancer Res Treat. 2006 Mar; 99(2):215-20.
HIV/AIDS and the Private Sector in Africa: Impact and Responses. Report prepared for the Commission on HIV/AIDS and Governance in Africa
Boston, MA: Center for International Health and Development; 2006 Feb.
Breast J. 2006 Jan; 12(1):2-6.
Boston, MA: Center for International Health and Development, Boston University; 2006.
Int J Epidemiol. 2005 Sep; 34(6):1370-6.
A Sensitivity Analysis of a Randomized Controlled Trial of Zinc in Treatment of Falciparum Malaria in Children
Contemp Clin Trials. 2005 May; 26(3):281-9.
Challenges in the Design of Antibiotic Equivalency Studies: The Multicenter Equivalency Study of Oral Amoxicillin versus Injectable Penicillin in Children aged 3-59 Months with Severe Pneumonia
Clin Infect Dis. 2004 Sep; 39(4):526-31.
Cost Impact of HIV/AIDS Infections in the Professional Labor Force in the Zambian Health Care System
XVth International AIDS Conference; 2004 Jul 1; Bangkok, Thailand.
AIDS. 2004 Apr; 18(2):317-24.
S Afr Med J. 2004 Mar; 94(2):125-30.
Trop Med Int Health. 2004 Mar; 9(3):318-24.
Boston, MA: Boston University Center for International Health and Development (USAID Funded); 2004.
Boston, MA: Center for International Health and Development; 2004.
Harv Bus Rev. 2003 Feb; 81(2):80-7, 125.